1. Home
  2. SKLZ vs INKT Comparison

SKLZ vs INKT Comparison

Compare SKLZ & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Skillz Inc.

SKLZ

Skillz Inc.

HOLD

Current Price

$2.87

Market Cap

57.3M

Sector

Technology

ML Signal

HOLD

Logo MiNK Therapeutics Inc.

INKT

MiNK Therapeutics Inc.

HOLD

Current Price

$9.40

Market Cap

57.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SKLZ
INKT
Founded
2012
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
57.3M
57.6M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
SKLZ
INKT
Price
$2.87
$9.40
Analyst Decision
Buy
Buy
Analyst Count
1
2
Target Price
$14.00
$35.00
AVG Volume (30 Days)
34.6K
149.8K
Earning Date
05-07-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
45.98
N/A
EPS
N/A
N/A
Revenue
$92,865,000.00
N/A
Revenue This Year
$13.33
N/A
Revenue Next Year
$12.68
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.10
$6.66
52 Week High
$9.11
$76.00

Technical Indicators

Market Signals
Indicator
SKLZ
INKT
Relative Strength Index (RSI) 36.99 40.74
Support Level N/A $6.80
Resistance Level $3.68 $12.64
Average True Range (ATR) 0.18 0.73
MACD -0.01 -0.13
Stochastic Oscillator 0.00 7.98

Price Performance

Historical Comparison
SKLZ
INKT

About SKLZ Skillz Inc.

Skillz Inc is a two-sided mobile gaming platform that connects developers with competitive players. The company's reportable business segments are: the Skillz segment and the Aarki segment. Skillz segment's highlights include Monetize Through Competitions, Player Matching, Cross-Platform Support, Comprehensive Analytics, and Focus on Game Development. Aarki is an artificial intelligence company that delivers advertising solutions. Some of the games available on its platform are Dominoes Gold, Blackout Bingo, 21 Blitz, and Solitaire Cube among others. The majority of its revenue is generated from the Skillz segment. Geographically, the company derives its key revenue from the United States and the rest from Israel, China, Malta, and other countries.

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Share on Social Networks: